Mutation of Spry2 Induces Proliferation and Differentiation of Osteoblasts but Inhibits Proliferation of Gingival Epithelial Cells

Journal of Cellular Biochemistry

Volumn 116, Issue 4, 2015, Pages 628-639

  Sanui, Terukazu ^a   Tanaka, Urara ^a   Fukuda, Takao ^a   Toyoda, Kyosuke ^a   Taketomi, Takaharu ^b   Atomura, Ryo ^a   Yamamichi, Kensuke ^a   Nishimura, Fusanori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

bFGF; EGF; GINGIVAL EPITHELIAL CELLS; OSTEOBLASTS; PERIODONTAL REGENERATION; Spry2

Indexed keywords

ALKALINE PHOSPHATASE; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; NERVE GROWTH FACTOR; OSTEOCALCIN; PLATELET DERIVED GROWTH FACTOR; SPROUTY 2 PROTEIN; SPROUTY PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR TWIST; TYROSINE; TYROSINE 55; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; FIBROBLAST GROWTH FACTOR 2; MEMBRANE PROTEIN; SIGNAL PEPTIDE; SPRY2 PROTEIN, MOUSE;

ALVEOLAR BONE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE GROWTH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; GENE MUTATION; GINGIVAL EPITHELIAL CELL; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE TRANSFORMATION; MOLECULAR BIOLOGY; MOUTH EPITHELIUM CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE REGENERATION; UBIQUITINATION; UPREGULATION; ANIMAL; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; GINGIVA; MOUSE; MUTATION; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GINGIVA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MUTATION; OSTEOBLASTS;

EID: 84943553905     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25014     Document Type: Article

References (44)

1. Brown LJ, Löe H,. 1993. Prevalence, extent, severity and progression of periodontal disease. Periodontol 2: 57-71.
2. Cho MI, Garant PR,. 2000. Development and general structure of the peridontium. Periodontol 24: 9-27.
3. Christofori G,. 2003. Split personalities: The agonistic antagonist Sprouty. Nat Cell Biol 5: 377-379.
4. Fong CW, Leong HF, Wong ESM, Lim J, Yusoff P, Guy GR,. 2003. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function. J Biol Chem 278: 33456-33464.
5. Goodnough LH, Brugmann SA, Hu D, Helms JA,. 2007. Stage-dependent craniofacial defects resulting from Sprouty2 overexpression. Dev Dyn 236: 1918-1928.
6. Gross I, Bassit B, Benezra M, Licht JD,. 2001. Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J Biol Chem 276: 46460-46468.
7. Guy GR, Jackson RA, Yusoff P, Chow SY,. 2009. Sprouty proteins: Modified modulators, matchmakers or missing links. J Endocrinol 203: 191-202.
8. Guy GR, Wong ESM, Yusoff P, Chandramouli S, Lo TL, Lim J, Fong CW,. 2003. Sprouty: How does the branch manager work. J Cell Sci 116: 3061-3068.
9. Hammarström L,. 1997. Enamel matrix, cementum development and regeneration. J Clin Periodontol 24: 658-668.
10. Hanafusa H, Torii S, Yasunaga T, Nishida E,. 2002. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 4: 850-858.
11. Hausott B, Vallant N, Auer M, Yang L, Dai F, Brand-Saberi B, Klimaschewski L,. 2009. Sprouty2 down-regulation promotes axon growth by adult sensory neurons. Mol Cell Neurosci 42: 328-340.
12. Heldin CH,. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80: 213-223.
13. Huang W, Carlsen B, Rudkin G, Berry M, Ishida K, Yamaguchi DT, Miller TA,. 2004. Osteopontin is a nengative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells. Bone 34: 799-808.
14. Impagntiello MA, Weitzer S, Gannon G, Compagni A, Cotton M, Christofori G,. 2001. Mammalian Sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol 152: 1087-1098.
15. Kim HJ, Bar-Sagi D,. 2004. Modulation of signalling by Sprouty: A developing story. Nat Rev Mol Cell Biol 5: 441-450.
16. Kitamura M, Akamatsu M, Machigashira M, Hara Y, Sakagami R, Hirofuji T, Hamachi T, Maeda K, Yokota M, Kido J, Nagata T, Kurihara H, Takashiba S, Sibutani T, Fukuda M, Noguchi T, Yamazaki K, Yoshie H, Ioroi K, Arai T, Nakagawa T, Ito K, Oda S, Izumi Y, Ogata Y, Yamada S, Shimauchi H, Kunimatsu K, Kawanami M, Fujii T, Furuichi Y, Furuuchi T, Sasano T, Imai E, Omae M, Yamada S, Watanuki M, Murakami S,. 2011. FGF-2 stimulates periodontal regeneration: Results of a multi-center randomized clinical trial. J Dent Res 90: 35-40.
17. Kitamura M, Nakashima K, Kowashi Y, Fujii T, Shimauchi H, Sasano T, Furuuchi T, Fukuda M, Noguchi T, Shibutani T, Iwayama Y, Takashiba S, Kurihara H, Ninomiya M, Kido J, Nagata T, Hamachi T, Maeda K, Hara Y, Izumi Y, Hirofuji T, Imai E, Omae M, Watanuki M, Murakami S,. 2008. Periodontal tissue regeneration using fibroblast growth factor-2: Randomized controlled phase II clinical trial. PLoS One 3: 2611.
18. Klein OD, Minowada G, Peterkova R, Kangas A, Yu BD, Lesot H, Peterka M, Jernvall J, Martin GR,. 2006. Sprouty genes control diastema tooth development via bidirectional antagonism of epithelial-mesenchymal FGF signaling. Dev Cell 11: 181-190.
19. Komori T,. 2011. Signaling network in RUNX2-dependent bone development. J Cell Biochem 112: 750-755.
20. Kramer S, Okabe M, Hacohen N, Krasnow MA, Hiromi Y,. 1999. Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila. Development 126: 2515-2525.
21. Lagronova-Churava S, Spoutil F, Vojtechova S, Lesot H, Peterka M, Klein OD, Peterkova R,. 2013. The dynamics of supernumerary tooth development are differentially regulated by Sprouty genes. J Exp Zool B Mol Dev Evol 320: 307-320.
22. Lee MS, Lowe GN, Strong DD, Wergedal JE, Glackin CA,. 1999. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 75: 566-577.
23. Lee CC, Putnam AJ, Miranti CK, Gustafson M, Wang LM, Vande Woude, Gao GF,. 2004. Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis. Oncogene 23: 5193-5202.
24. Mason JM, Morrison DJ, Basson MA, Licht JD,. 2006. Sprouty proteins: Multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol 16: 45-54.
25. Matsumura K, Taketomi T, Yoshizaki K, Arai S, Sanui T, Yoshiga D, Yoshimura A, Nakamura S,. 2011. Sprouty2 controls proliferation of palate mesenchymal cells via fibroblast growth factor signaling. Biochem Biophys Res Commun 404: 1076-1082.
26. Murray SS, Glackin CA, Winters KA, Gazit D, Kahn AJ, Murray EJ,. 1992. Expression of herix-loop-herix regulatory genes during differentiation of mouse osteoblastic cells. J Bone Miner Res 7: 1131-1138.
27. Nakamura T, Toita H, Yoshimoto A, Nishimura D, Takagi T, Ogawa T, Takeya T, Ishida-Kitagawa N,. 2010. Potential involvement of Twist2 and Erk in the regulation of osteoblastogenesis by HB-EGF-EGFR signaling. Cell Struct Funct 35: 53-61.
28. Okur MN, Russo A, O'Bryan JP,. 2014. Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase. Mol Biol Cell 34: 271-279.
29. Pihlstrom BL, Michalowicz BS, Johnson NW,. 2005. Periodontal diseases. Lancet 366: 1809-1820.
30. Rathmanner N, Haigl B, Vana V, Doriguzzi A, Gsur A, Sutterlüty H,. 2013. Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cells. FEBS Lett 587: 2597-2605.
31. Ratka-Krüger P, Neukranz E, Raetzke P,. 2000. Guided tissue regeneration procedure with bioresorbable membranes versus conventional flap surgery in the treatment of infrabony periodontal defects. J Clin Periodontol 27: 120-127.
32. Rice DP, Aberg T, Chan Y, Tang Z, Kettunen PJ, Pakarinen L, Maxson RE, Thesleff I,. 2000. Integration of FGF and twist in calvarial bone and suture development. Development 127: 1845-1855.
33. Rubin C, Litvak V, Medvedovsky H, Zwang Y, Lev S, Yarden Y,. 2003. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops. Curr Biol 13: 297-307.
34. Sasaki A, Taketomi T, Wakioka T, Kato R, Yoshimura A,. 2001. Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J Biol Chem 276: 36804-36808.
35. Singh S, Mak IW, Cowan RW, Turcotte R, Singh G, Ghert M,. 2011. The role of TWIST as a regulator in gaiant cell tumor of bone. J Cell Biochem 112: 2287-2295.
36. Singh S, Singh M, Mak IWY, Turcotte R, Ghert M,. 2012. Investigation of FGFR2-IIIC signaling via FGF-2 ligand for advancing GCT stromal cell differentiation. PLoS One 7: 46769.
37. Taniguchi K, Sasaki K, Watari K, Yasukawa H, Imaizumi T, Ayada T, Okamoto F, Ishizaki T, Kato R, Kohno R, Kimura H, Sato Y, Ono M, Yonemitsu Y, Yoshimura A,. 2009. Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis. PLoS One 4: 5467.
38. Villar CC, Cochran DL,. 2010. Regeneration of periodontal tissues: Guided tissue regeneration. Dent Clin North Am 54: 73-92.
39. Wietecha MS, Chen L, Ranzer MJ, Anderson K, Ying C, Patel TB, DiPietro LA,. 2011. Sprouty2 downregulates angiogenesis during mouse skin wound healing. Am J Physiol Heart Circ Physiol 300: H459-H467.
40. Wong ES, Fong CW, Lim J, Yusoff P, Low BC, Langdon WY, Guy GR,. 2002. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO J 21: 4796-4808.
41. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT,. 2002. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor. Cbfa1/Runx2 J Biol Chem 277: 36181-36187.
42. Yang X, Webster JB, Kovalenko D, Nadeau RJ, Zubanova O, Chen PY, Friesel R,. 2006. Sprouty2 genes are expressed in osteoblasts and inhibit fibroblast growth factor-mediated osteoblast responses. Calcif Tissue Int 78: 233-240.
43. Yusoff P, Lao DH, Ong SH, Wong ES, Lim J, Lo TL, Leong HF, Fong CW, Guy GR,. 2002. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 277: 3195-3201.
44. Zhu J, Shimizu E, Zhang X, Partridge NC, Qin L,. 2011. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. J Cell Biochem 112: 1749-1760.